These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 9003520)

  • 21. 2,4,6-Trisubstituted pyridines: Synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship.
    Basnet A; Thapa P; Karki R; Na Y; Jahng Y; Jeong BS; Jeong TC; Lee CS; Lee ES
    Bioorg Med Chem; 2007 Jul; 15(13):4351-9. PubMed ID: 17493824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complex response of breast epithelial cell lines to topoisomerase inhibitors.
    Davis PL; Shaiu WL; Scott GL; Iglehart JD; Hsieh TS; Marks JR
    Anticancer Res; 1998; 18(4C):2919-32. PubMed ID: 9713486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and biological evaluation of 10,11-methylenedioxy-14-azacamptothecin.
    Elban MA; Sun W; Eisenhauer BM; Gao R; Hecht SM
    Org Lett; 2006 Aug; 8(16):3513-6. PubMed ID: 16869648
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure-activity relationships for substituted bis(acridine-4-carboxamides): a new class of anticancer agents.
    Gamage SA; Spicer JA; Atwell GJ; Finlay GJ; Baguley BC; Denny WA
    J Med Chem; 1999 Jul; 42(13):2383-93. PubMed ID: 10395479
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and antitumor activity evaluation of a novel series of camptothecin analogs.
    Lv J; Guo N; Wen SP; Teng YO; Ma MX; Yu P
    J Asian Nat Prod Res; 2013; 15(8):867-74. PubMed ID: 23796391
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel tetra-acridine derivatives as dual inhibitors of topoisomerase II and the human proteasome.
    Vispé S; Vandenberghe I; Robin M; Annereau JP; Créancier L; Pique V; Galy JP; Kruczynski A; Barret JM; Bailly C
    Biochem Pharmacol; 2007 Jun; 73(12):1863-72. PubMed ID: 17391647
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inactivation of p53 increases the cytotoxicity of camptothecin in human colon HCT116 and breast MCF-7 cancer cells.
    Gupta M; Fan S; Zhan Q; Kohn KW; O'Connor PM; Pommier Y
    Clin Cancer Res; 1997 Sep; 3(9):1653-60. PubMed ID: 9815856
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aromatic analogues of DNA minor groove binders--synthesis and biological evaluation.
    Pućkowska A; Bielawski K; Bielawska A; Midura-Nowaczek K
    Eur J Med Chem; 2004 Jan; 39(1):99-105. PubMed ID: 14987838
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and antitumor properties of N-[2-(dimethylamino)ethyl]carboxamide derivatives of fused tetracyclic quinolines and quinoxalines: a new class of putative topoisomerase inhibitors.
    Deady LW; Kaye AJ; Finlay GJ; Baguley BC; Denny WA
    J Med Chem; 1997 Jun; 40(13):2040-6. PubMed ID: 9207945
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of indenoisoquinoline topoisomerase I inhibitors using a hollow fiber assay.
    Morrell A; Jayaraman M; Nagarajan M; Fox BM; Meckley MR; Ioanoviciu A; Pommier Y; Antony S; Hollingshead M; Cushman M
    Bioorg Med Chem Lett; 2006 Aug; 16(16):4395-9. PubMed ID: 16750365
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Total and semisynthesis and in vitro studies of both enantiomers of 20-fluorocamptothecin.
    Tangirala RS; Dixon R; Yang D; Ambrus A; Antony S; Agama K; Pommier Y; Curran DP
    Bioorg Med Chem Lett; 2005 Nov; 15(21):4736-40. PubMed ID: 16140529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural modification of 3-arylisoquinolines to isoindolo[2,1-b]isoquinolinones for the development of novel topoisomerase 1 inhibitors with molecular docking study.
    Van HT; Cho WJ
    Bioorg Med Chem Lett; 2009 May; 19(9):2551-4. PubMed ID: 19328687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Substitution at the F-ring N-imide of the indolocarbazole antitumor drug NB-506 increases the cytotoxicity, DNA binding, and topoisomerase I inhibition activities.
    Bailly C; Qu X; Chaires JB; Colson P; Houssier C; Ohkubo M; Nishimura S; Yoshinari T
    J Med Chem; 1999 Jul; 42(15):2927-35. PubMed ID: 10425102
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and cytotoxic activity of polyamine analogues of camptothecin.
    Dallavalle S; Giannini G; Alloatti D; Casati A; Marastoni E; Musso L; Merlini L; Morini G; Penco S; Pisano C; Tinelli S; De Cesare M; Beretta GL; Zunino F
    J Med Chem; 2006 Aug; 49(17):5177-86. PubMed ID: 16913706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antitumor agents. 185. Synthesis and biological evaluation of tridemethylthiocolchicine analogues as novel topoisomerase II inhibitors.
    Guan J; Zhu XK; Tachibana Y; Bastow KF; Brossi A; Hamel E; Lee KH
    J Med Chem; 1998 May; 41(11):1956-61. PubMed ID: 9599244
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 2,2-dimethyl-2H-pyran-derived alkaloids I. Practical synthesis of acronycine and benzo[b]acronycine and their biological properties.
    Motiur Rahman AF; Liang JL; Lee SH; Son JK; Jung MJ; Kwon Y; Jahng Y
    Arch Pharm Res; 2008 Sep; 31(9):1087-93. PubMed ID: 18806949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oligopyrrole carboxamides linked with a nucleobase as potential DNA minor groove binding ligands: synthesis, DNA binding and biological evaluation.
    Keuser C; Pindur U
    Pharmazie; 2006 Apr; 61(4):261-8. PubMed ID: 16649534
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel autoxidative cleavage reaction of 9-fluoredenes discovered during synthesis of a potential DNA-threading indenoisoquinoline.
    Xiao X; Antony S; Kohlhagen G; Pommier Y; Cushman M
    J Org Chem; 2004 Oct; 69(22):7495-501. PubMed ID: 15497974
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New benzoxanthone derivatives as topoisomerase inhibitors and DNA cross-linkers.
    Cho HJ; Jung MJ; Woo S; Kim J; Lee ES; Kwon Y; Na Y
    Bioorg Med Chem; 2010 Feb; 18(3):1010-7. PubMed ID: 20093033
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distinct patterns of cell cycle disturbance elicited by compounds interfering with DNA topoisomerase I and II activity.
    Poot M; Hiller KH; Heimpel S; Hoehn H
    Exp Cell Res; 1995 May; 218(1):326-30. PubMed ID: 7537696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.